Back to Search
HECTOR GOMEZ, MD
MD
Student in an Organized Health Care Education/Training Program
NPI: 1013777655Individual
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Research & Publications (20)
Efficacy and safety of lapatinib as first-line therapy for ErbB2-amplified locally advanced or metastatic breast cancer.
PMID 18458039·J Clin Oncol·2008
3-trial
A phase II trial of pemetrexed in advanced breast cancer: clinical response and association with molecular target expression.
PMID 16467096·Clin Cancer Res·2006
3-trial
Lactoferrin protects rabbits from Shigella flexneri-induced inflammatory enteritis.
PMID 12438385·Infect Immun·2002
7-preclinical
A new assay for the detection of Loxosceles species (brown recluse) spider venom.
PMID 11973553·Ann Emerg Med·2002
4-observational
Antigenic cross-reactivity of venoms from medically important North American Loxosceles spider species.
PMID 11137541·Toxicon·2001
7-preclinical
Protective role of human lactoferrin against invasion of Shigella flexneri M90T.
PMID 11787716·Adv Exp Med Biol·2001
8-other
A phase II study of neoadjuvant gemcitabine plus doxorubicin in stage IIIB breast cancer: a preliminary report.
PMID 11510035·Semin Oncol·2001
3-trial
Direct correlation between diffusion of Loxosceles reclusa venom and extent of dermal inflammation.
PMID 11282664·Acad Emerg Med·2001
4-observational
Analysis of dermatologic events in patients with cancer treated with lapatinib.
PMID 18600445·Breast Cancer Res Treat·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 200 UCLA MEDICAL PLZ
LOS ANGELES, CA 90095 - Phone
- (310) 206-6688
Quick Facts
- NPI
- 1013777655
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile